White House Moves to Take Control of N.I.H. Grants
Federal officials are drafting an executive order that would place grants under review by an outside panel, the latest effort to redirect billions of dollars in research spending.
The White House's move to take control of National Institutes of Health (N.I.H.) grants has significant implications for the scientific research community. By placing grants under review by an outside panel, the administration is asserting its influence over the allocation of billions of dollars in research funding. This development is likely to be closely watched by researchers, policymakers, and industry stakeholders who rely on N.I.H. grants to advance medical research and innovation.
The proposed executive order is part of a broader effort by the administration to redirect research spending and potentially reshape the priorities of the N.I.H. This move has sparked concerns among scientists and research advocates, who worry that it could lead to politicization of the grant-making process and undermine the independence of the N.I.H. The N.I.H. is a major source of funding for biomedical research, and its grants support a wide range of projects, from basic scientific inquiry to clinical trials.
What's next to watch is how the proposed executive order is received by the scientific community and Congress. Researchers and lawmakers may push back against the plan, arguing that it could disrupt the research pipeline and compromise the integrity of the grant-making process. The administration's priorities for research spending and the role of the N.I.H. are likely to be key areas of debate in the coming months. As the situation unfolds, it's essential to monitor the impact on the research community and the potential consequences for medical innovation and progress.
Originally reported by nytimes.com. VPNews adds analysis for general news readers.